Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gramatzki

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Journal of Immunological Methods|July 16, 2011
Human kappa light chain targeted Pseudomonas exotoxin A--identifying human antibodies and Fab fragments with favorable characteristics for antibody-drug conjugate developmentC Kellner, W K Bleeker, J J Lammerts van Bueren, et al.
Journal of Internal Medicine|February 7, 2019
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial HypertensionS Bringhen, A Milan, M D'Agostino, et al.
Bone Marrow Transplantation|January 24, 2017
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow TransplantationJ Schetelig, L C de Wreede, M van Gelder, et al.
Leukemia|December 6, 2012
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemiaH Pfeifer, B Wassmann, W Bethge, et al.
Bone Marrow Transplantation|July 1, 1997
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cellsH D Ottinger, E Albert, R Arnold, et al.
Bone Marrow Transplantation|December 13, 2016
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow TransplantationM van Gelder, L C de Wreede, M Bornhäuser, et al.
Blood|January 15, 1996
Improved outcome in adult B-cell acute lymphoblastic leukemiaD Hoelzer, W D Ludwig, E Thiel, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Journal of Immunological Methods|July 16, 2011
Human kappa light chain targeted Pseudomonas exotoxin A--identifying human antibodies and Fab fragments with favorable characteristics for antibody-drug conjugate developmentC Kellner, W K Bleeker, J J Lammerts van Bueren, et al.
Journal of Internal Medicine|February 7, 2019
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial HypertensionS Bringhen, A Milan, M D'Agostino, et al.
Bone Marrow Transplantation|January 24, 2017
Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow TransplantationJ Schetelig, L C de Wreede, M van Gelder, et al.
Leukemia|December 6, 2012
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemiaH Pfeifer, B Wassmann, W Bethge, et al.
Bone Marrow Transplantation|July 1, 1997
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cellsH D Ottinger, E Albert, R Arnold, et al.
Bone Marrow Transplantation|December 13, 2016
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow TransplantationM van Gelder, L C de Wreede, M Bornhäuser, et al.
Blood|January 15, 1996
Improved outcome in adult B-cell acute lymphoblastic leukemiaD Hoelzer, W D Ludwig, E Thiel, et al.
Pageof 9